These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29037499)

  • 41. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC; Hodges JR; Macdonald V; Cordato NJ; Kril JJ; Halliday GM
    Mov Disord; 2011 Feb; 26(2):256-63. PubMed ID: 21412832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization and diagnostic potential of R
    Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
    Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.
    Wittstock M; Pohley I; Walter U; Grossmann A; Benecke R; Wolters A
    J Neural Transm (Vienna); 2013 Mar; 120(3):453-61. PubMed ID: 22892823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.
    Ye R; Hezemans FH; O'Callaghan C; Tsvetanov KA; Rua C; Jones PS; Holland N; Malpetti M; Murley AG; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    J Neurosci; 2023 Oct; 43(42):7028-7040. PubMed ID: 37669861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W
    Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Necpál J; Borsek M; Jeleňová B
    Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Duff K; McDermott D; Luong D; Randolph C; Boxer AL
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):469-475. PubMed ID: 30712468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The language profile of progressive supranuclear palsy.
    Catricalà E; Boschi V; Cuoco S; Galiano F; Picillo M; Gobbi E; Miozzo A; Chesi C; Esposito V; Santangelo G; Pellecchia MT; Borsa VM; Barone P; Garrard P; Iannaccone S; Cappa SF
    Cortex; 2019 Jun; 115():294-308. PubMed ID: 30884283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioral abnormalities in progressive supranuclear palsy.
    Gerstenecker A; Duff K; Mast B; Litvan I;
    Psychiatry Res; 2013 Dec; 210(3):1205-10. PubMed ID: 24035530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropsychiatric aspects of progressive supranuclear palsy.
    Litvan I; Mega MS; Cummings JL; Fairbanks L
    Neurology; 1996 Nov; 47(5):1184-9. PubMed ID: 8909427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.
    Lee Y; Lee DK; Lee JM; Chung SJ; Lee JJ; Sohn YH; Lee PH
    Eur J Neurol; 2017 Jan; 24(1):212-218. PubMed ID: 27747983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Track density imaging in progressive supranuclear palsy: A pilot study.
    Nigro S; Bianco MG; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Augimeri A; Quattrone A
    Hum Brain Mapp; 2019 Apr; 40(6):1729-1737. PubMed ID: 30474903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smaller and Denser Speech Graphs in Nondemented Patients with Progressive Supranuclear Palsy.
    Ma J; Zhang G; Sun X; Chan P; Ye Z
    Behav Neurol; 2023; 2023():3771601. PubMed ID: 37790602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thalamic hypoperfusion in early stage of progressive supranuclear palsy (Richardson's syndrome): report of an autopsy-confirmed case.
    Kobayashi Z; Akaza M; Ishihara S; Tomimitsu H; Inadome Y; Arai T; Akiyama H; Shintani S
    J Neurol Sci; 2013 Dec; 335(1-2):224-7. PubMed ID: 24075472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy.
    Lin WY; Lin KJ; Weng YH; Yen TC; Shen LH; Liao MH; Lu CS
    Nucl Med Commun; 2010 Nov; 31(11):974-80. PubMed ID: 20717064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.